By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 119.41 |
Change Today | $ 0.00 |
% Change | 0.00 % |
52 Week High | $121.38 |
52 Week Low | $114.80 |
Volume | 13,753 |
Shares Issued | 1,246.00m |
Market Cap | $148,785m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 11 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
You are here: research